Risk of Myocardial Infarction and Death After Noncardiac Surgery Performed Within the First Year After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome or Stable Angina Pectoris

Approximately 1 in 5 patients undergo noncardiac surgery within the first year after a drug-eluting stent (DES) implantation.1 –3 For these patients, it is recommended that a multidisciplinary team, including cardiologists and surgeons, evaluates the indication for and timing of the surgery and the consequences of interrupting dual antiplatelet therapy (DAPT). Such consequences include an increased risk of thrombotic even ts such as stent thrombosis and risk of bleeding associated with surgery.4,5 Based on 2 recent cohort studies,3,6 the 2018 European Society of Cardiology DAPT consensus document suggested that when surgical delay is undesired, elective surgery may be considered 1 month after DES implantation for st able angina pectoris (SAP) and 6 months after DES implantation for acute coronary syndrome (ACS).
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research